Blood Testing Market Size Worth USD 177 Billion By 2032 |...

Blood Testing Market Size Worth USD 177 Billion By 2032

Posted 2024-03-01 04:51:23

Market Overview: In 2022, the global blood testing market reached a valuation of USD 86.6 billion, with projections indicating it will grow to USD 177 billion by 2032, showcasing a revenue compound annual growth rate (CAGR) of 8.3% over the forecast period. The surge in chronic ailments like cancer, diabetes, and cardiovascular diseases, coupled with the growing necessity for early disease detection and advancements in blood testing technologies, are driving the market's revenue expansion.

The rise in the prevalence of chronic diseases, emphasized by the World Health Organization (WHO) linking 71% of global deaths to such conditions, emphasizes the crucial importance of blood testing in identifying diseases. The need for early detection and treatment to reduce mortality rates is driving the demand for blood testing methods, leading to an increase in market revenue growth.

Get a sample copy of the Blood Testing Market report: https://www.reportsanddata.com/download-free-sample/6264

Technological enhancements also contribute significantly to revenue growth, with innovations such as liquid biopsy facilitating early cancer detection. Additionally, the advent of point-of-care and portable blood testing devices is enhancing patient accessibility and convenience, further driving market revenue.

Government initiatives aimed at bolstering healthcare infrastructure and broadening healthcare service access are instrumental in fueling revenue growth. For instance, India's National Health Mission is pivotal in spurring demand for blood testing services, striving to ensure universal access to affordable, high-quality healthcare.

Nonetheless, obstacles such as the high cost of blood testing procedures and a scarcity of skilled professionals may impede market revenue growth. Furthermore, the availability of alternative diagnostic techniques like imaging testing poses a challenge to market expansion.

Key Insights:

Test Type Analysis:

The blood glucose test segment dominated the market in 2022 due to the escalating prevalence of diabetes globally.
Blood chemistry tests are anticipated to exhibit the fastest revenue CAGR during the forecast period, driven by their widespread use in diagnosing various illnesses.
Full blood count tests are expected to witness a notably rapid revenue CAGR owing to the growing need for diagnosing blood disorders and chronic diseases.

End-use Analysis:

Hospitals and clinics held the largest revenue share in 2022, attributed to the surge in chronic diseases and hospital admissions, coupled with investments in healthcare infrastructure.
Diagnostic laboratories are projected to register the fastest revenue CAGR, driven by the increasing demand for diagnostic tests and procedures.
Home care settings are anticipated to witness a significantly rapid revenue CAGR, fueled by the preference for home-based healthcare services, especially among chronic disease patients and the elderly.

Regional Analysis:

North America is forecasted to command the largest revenue share, driven by high chronic disease prevalence and investments in R&D.
Asia Pacific is expected to exhibit the fastest revenue CAGR, buoyed by population growth and rising chronic disease incidence, notably in countries like China and India.
Europe is poised for moderate revenue growth, supported by a growing elderly population and favorable government policies.

Major Companies: The global blood testing market is characterized by intense competition, with key players including Abbott Laboratories, Becton, Dickinson and Company, and F. Hoffmann-La Roche Ltd., among others. Revenue growth is anticipated, driven by factors like increasing chronic disease prevalence and the availability of innovative blood testing technologies.

Strategic Developments:

Thermo Fisher Scientific's acquisition of PPD, Inc. aims to bolster its presence in the clinical research and blood testing markets.
Abbott Laboratories' launch of the Alinity platform enhances blood testing efficiency and accuracy.
Siemens Healthineers' acquisition of Fast Track Diagnostics strengthens its position in the infectious disease testing market.

New Product Launches:

F. Hoffmann-La Roche Ltd.'s cobas e 801 module offers high-volume testing for various diseases, catering to the demand for efficient diagnostic solutions.

Market Segmentation: The report segments the market based on test type, end-use, and region, providing insights into market trends and forecasts from 2019 to 2032.

The Blood Testing Market: Report Scope:

Market size in 2022: USD 86.6 billion
CAGR (2022-2032): 8.3%
Revenue forecast in 2032: USD 177 billion
Scope: Test type, end-use, regional analysis
Coverage: Historical data (2020-2021) and forecast period (2022-2032)
Units: Revenue in USD billion
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Customization Scope: The report offers 10 hours of free customization and expert consultation to meet specific requirements.

Explore Trending Reports:

Pressure Sensitive Adhesives Market-https://www.reportsanddata.com/report-detail/pressure-sensitive-adhesive-market

Construction Adhesive Market-https://www.reportsanddata.com/report-detail/construction-adhesive-market

Basalt Fiber Market-https://www.reportsanddata.com/report-detail/basalt-fiber-market

Ammonium Nitrate Market-https://www.reportsanddata.com/report-detail/ammonium-nitrate-market

Roofing Systems Market-https://www.reportsanddata.com/report-detail/roofing-systems-market

Polyimide Films Market-https://www.reportsanddata.com/report-detail/polyimide-film-market

Plastic Fasteners Market-https://www.reportsanddata.com/report-detail/plastic-fasteners-market

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/6264

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports